What is the actual cost of regorafenib after Medicare?
Regorafenib , as an innovative multi-target kinase inhibitor, has been widely used in the treatment of a variety of advanced cancers, such as metastatic colorectal cancer, gastrointestinal stromal tumors and hepatocellular carcinoma. Since Regorafenib was launched in my country and entered the medical insurance system, it has brought good news to cancer patients and significantly reduced their financial pressure.
Currently, Regorafenib (Regofenib) has been included in the medical insurance drug catalog, and patients’ out-of-pocket expenses when purchasing it have been significantly reduced. After medical insurance, the domestic price of regorafenib (regorafenib) is about four to five thousand yuan. However, it needs to be made clear that this price and the specific reimbursement amount of medical insurance may be affected by factors such as regional differences and hospital policies. To ensure the most accurate information, patients are advised to consult their local hospital pharmacy for detailed consultation before purchasing medicines.

In addition, for patients who want to seek more economical benefits, there are alsoregorafenib original drugs and generic drugs available in foreign markets. The price of the Turkish version of the original drug is about more than 1,000 yuan. The price of generic drugs in Laos, India, Bangladesh and other places is more affordable, ranging from a few hundred yuan to more than a thousand yuan. Importantly, the main ingredients of these medicines are basically the same as the original medicines, so their therapeutic effects are similar.
In general, although the domestic price of regorafenib (regorafenib) after medical insurance is about four to five thousand yuan, it has been significantly reduced compared to the previous price, which undoubtedly brings real benefits to patients. For those patients who want to further save costs, foreign original drugs and generic drugs also provide them with more choices. Regardless of whether they are domestic or foreign drugs, patients should choose and use them under the guidance of a doctor to ensure the safety and effectiveness of treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)